FMP
Fidelity Select Biotechnology Portfolio
FBIOX
NASDAQ
The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
19.25 USD
0.03 (0.156%)
We are unable to load the chart at this time.
N/A
N/A
N/A
N/A
NASDAQ
The fund invests primarily in common stocks. It normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
0000320351
US3163907724
316390772
Fidelity Select Portfolios
800-544-8544
US
N/A
Dec 16, 1985
We are unable to load the chart at this time.
We are unable to load the chart at this time.
0000320351
NASDAQ
-
-
316390772
US3163907724
US
19.25
0.68
0
4.75B
-
17.43-22.47
0
-
-
-
-
-
-
-
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.